Explore 3 Stock Ideas & Industry Insights Download Free Report

News

22nd Century Group S-8 Filed After 1-for-58 Reverse Split

22nd Century Group, Inc. filed a Form S-8 registration statement with the SEC on November 16, 2026, to register additional shares under its Amended and Restated 2021 Omnibus Incentive Plan following a 1-for-58 reverse stock split completed in November 2026.

Manish Choudhary | 16 November 2026

MapLight Therapeutics Q3 2026 Results and Investor Presentation

MapLight Therapeutics, Inc. filed a Current Report on Form 8-K on November 16, 2026, announcing its financial results for the third quarter ended September 30, 2026, and an updated corporate presentation furnished under Regulation FD.

Aditi Sarkar | 16 November 2026

QVC Group Q3 2026 10-Q: 49,999,897 Shares Outstanding

QVC Group, Inc. filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission covering the fiscal quarter ended September 30, 2026, disclosing its financial position, results of operations, and material risk factors following its emergence from Chapter 11 bankruptcy proceedings.

Manish Choudhary | 16 November 2026

Macerich Acquires Oakridge Mall in San Jose for $250 Million

The Macerich Company filed an 8-K with the SEC on November 16, 2026, disclosing its acquisition of Oakridge Mall in San Jose, California, for a purchase price of approximately $250 million.

Vinay Lochav | 16 November 2026

Rafael De La Vega Buys 2,297 Amdocs Shares at $44.505

Director Rafael De La Vega filed a Form 4 with the SEC on November 16, 2026, disclosing a purchase of Amdocs Ltd ordinary shares on November 12, 2026.

Aditi Sarkar | 16 November 2026

Xtant Medical Files Q3 2026 Report With 140.4M Shares Out

Xtant Medical Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, disclosing operational details, strategic developments, and a share count of 140,452,061 as of November 13, 2026.

Aakashdeep | 16 November 2026

Barrel Energy Posts $1.52M Nine-Month Net Loss, Q3 2026

Barrel Energy, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting a net loss of $1,518,216 for the nine months ended September 30, 2026.

Anjali Anand | 16 November 2026

Prelude Therapeutics Q3 2026: Net Loss Narrows to $12.5M

Prelude Therapeutics Incorporated filed its quarterly report on Form 10-Q with the SEC on November 16, 2026, covering the three and nine months ended September 30, 2026.

Vinay Lochav | 16 November 2026

Instil Bio Reports Q3 2026 Net Loss of $4.2 Million

Instil Bio, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, disclosing a net loss of $4.231 million for the third quarter and $13.023 million for the nine months ended September 30, 2026.

Shwetambri Chauhan | 16 November 2026

Translational Development Acquisition Q3 2026 10-Q

Translational Development Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 16, 2026, reporting a net loss of $9,293,622 for the third quarter and disclosing a new $10,200,000 Subscription Agreement liability on its balance …

Manish Choudhary | 16 November 2026
Support

Hi! How can we help you today?

Loading…